NMPA holds meeting to promote construction of drug regulation quality management system

On July 26, the National Medical Products Administration (NMPA) held a meeting on the construction of the drug regulation quality management system at the Center for Medical Device Evaluation in Beijing.

NMPA Commissioner Jiao Hong addressed the meeting. Xu Jinghe and Zhao Junning, deputy commissioners of the NMPA, and the director for drug safety of the NMPA participated in the meeting.

Jiao said that establishing a drug regulation quality management system is an urgent need to comprehensively strengthen the nation’s drug regulation capabilities, accelerate the modernization and internationalization of drug regulation, and to promote the high-quality development of the industry.

She urged great efforts to thoroughly implement the guiding principles of the 20th National Congress of the Communist Party of China, carefully summarize the experiences of constructing and operating the national vaccine regulation quality management system, and draw on the successful practices of the highly efficient integration of quality management systems and regulatory work at such institutions as the Center for Medical Device Evaluation, in a bid to comprehensively advance the construction of the drug regulation quality management system.

It is also of great importance to promote the in-depth integration of quality management and regulatory work, enhance the connection and coordination of quality management systems between the NMPA and provincial-level medical products administrations, and continuously improve the nation’s drug regulation capabilities, so as to effectively ensure the safety, effectiveness, and accessibility of drugs for the public and contribute to the advancement of drug regulation through a Chinese path to modernization, she said.

At the meeting, representatives of the Center for Medical Device Evaluation expounded on the construction and ongoing operation of the quality management system of medical device evaluation. Representatives of the National Institute for Food and Drug Control, the Center for Drug Evaluation, and the Center for Food and Drug Inspection shared their experiences. Officials of related NMPA departments and its affiliated institutions also participated in the event.